In our previous study, we demonstrated that Pgrmc1 loss in HFD‐fed mice exacerbated hepatic steatosis and steatohepatitis through enhanced de novo lipogenesis, a liver‐specific metabolic pathway that generates malonyl‐CoA for fatty acid synthesis. The gene discussed is PGRMC1; the disease is fatty liver disease.